About
NRDL+ Executive Debrief helps senior life sciences decision-makers stay ahead of critical developments shaping China’s access landscape for innovative medicines.
- Newsletter: Join top life sciences leaders, expert consultants, and leading university researchers by subscribing to our free newsletter.
- Access360: Our innovative online program fuses policy intelligence with executive learning, helping global life sciences leaders anticipate—and act on—the forces reshaping access to innovative medicines in China.
- Consulting: For personalized support, we offer tailored access policy research and executive training programs focused on the China market.
Across all our offerings—whether the free newsletter, Access360, or customized consulting—NRDL+ Executive Debrief delivers carefully researched, actionable insights to support strategic decision-making at every level.
NRDL+ Executive Debrief is powered by bizi LLC, a New Jersey-based market access agency with over a decade of experience helping life sciences leaders navigate pricing, reimbursement, and access challenges across global and local markets.
People
Kelly Ke, Creator NRDL+ Executive Debrief, and Founder bizi
For more than two decades, Kelly balanced consulting with entrepreneurship. She thrived as an award-winning senior advisor at Deloitte US's life sciences practice for ten years, then focused on building bizi, an access agency aiding life sciences firms with pricing, reimbursement, and access challenges in the US and globally.
She created the NRDL+ newsletter and related services to bridge the gap in English-language resources on China's innovative medicine access landscape. These services focus on elucidating China's access policies and pathways for innovative medical technologies, boasting a membership that includes leaders from top-tier life sciences companies, prominent university researchers, and expert consultants from both leading consultancies and independent practices.
Born and raised in Beijing, China, and with extensive professional experience in the US, Kelly holds a unique global perspective. She holds a B.S. in materials physics from the University of Science and Technology Beijing, an M.S. in Materials Science from the University of Southern California, and an M.B.A. from the University of Utah. She has also earned a post-graduate certificate in International Health Technology Assessment and Reimbursement from the University of Sheffield in the UK.